{"id":35402,"date":"2015-04-30T08:26:40","date_gmt":"2015-04-30T12:26:40","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=35402"},"modified":"2015-04-30T08:26:40","modified_gmt":"2015-04-30T12:26:40","slug":"pfizer-inc-nysepfe-testing-support-band-in-33-50-34-00","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-testing-support-band-in-33-50-34-00-35402","title":{"rendered":"Pfizer Inc. (NYSE:PFE) \u2013 Testing Support Band In $33.50-$34.00"},"content":{"rendered":"<p style=\"text-align: justify;\"><strong>Pfizer Inc. (NYSE:PFE)<\/strong> spent the last trading session almost flat as it ended the day with a minor loss of 0.55% but the next trading may take a different color after the announcement of the last quarterly results. The company has beat the street estimates overcoming the patent expirations and Dollar strength but the guidance for the year has been lowered exactly for these two factors.<\/p>\n<p style=\"text-align: justify;\">Pfizer Inc. (NYSE:PFE) has increased the earnings by 2% to $0.38 per share or just under $2.38 billion. The adjusted profit of $0.51 beat the estimates by $0.01. The revenue dropped by 4% to $10.86 billion but still above the expectations. In the guidance on revenue for 2015, a negative impact of $3.5 billion due to generic competition is included, coupled with another negative impact of $3.3 billion from currency exchange.<\/p>\n<p style=\"text-align: justify;\"><a href=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/04\/PFE.jpg\"><img fetchpriority=\"high\" decoding=\"async\" class=\" size-full wp-image-35403 aligncenter\" src=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/04\/PFE.jpg\" alt=\"PFE\" width=\"664\" height=\"474\" srcset=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/04\/PFE.jpg 664w, https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/04\/PFE-300x214.jpg 300w, https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/04\/PFE-77x55.jpg 77w\" sizes=\"(max-width: 664px) 100vw, 664px\" \/><\/a><\/p>\n<p style=\"text-align: justify;\">The sales of Celebrex, the pain and arthritis drug of the company, dropped by 67% to $205 million as the generic rivals ate up the market, just like the case of the antibiotic Zyvox, which dropped by 10% to $271 million. The company thinks that the solution lies in acquiring new companies like Hospira Inc. for approximately $15.23 billion, to tap into the growing market of the biosimilars.<\/p>\n<p style=\"text-align: justify;\">Now there is a rumor in the air that Pfizer Inc. (NYSE:PFE) has fixed <strong>GlaxoSmithKline plc (ADR) (NYSE:GSK)<\/strong> as its major acquisition target, which is even bigger than <strong>AstraZeneca plc (ADR) (NYSE:AZN)<\/strong>, the target of the last failed acquisition attempt. GSK has 115,000 workers all over the world, including 13,000 in UK. If this rumor turns out to be true and the company really manages to get GSK, then that could be a fantastic boost to the stock price.<\/p>\n<p style=\"text-align: justify;\">The price is already testing the technical support band of $33.50-$34.00 and that may push the price higher to $35.50 once again.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pfizer Inc. (NYSE:PFE) spent the last trading session almost flat as it ended the day with a minor loss of 0.55% but the next trading [&hellip;]<\/p>\n","protected":false},"author":13,"featured_media":27742,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[4503,1734,4504,1735,993,2745],"stock_ticker":[],"class_list":["post-35402","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-astrazeneca-plc-adr-nyseazn","tag-glaxosmithkline-plc-adr-nysegsk","tag-nyseazn","tag-nysegsk","tag-nysepfe","tag-pfizer-inc-nysepfe","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pfizer Inc. (NYSE:PFE) \u2013 Testing Support Band In $33.50-$34.00 - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-testing-support-band-in-33-50-34-00-35402\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pfizer Inc. (NYSE:PFE) \u2013 Testing Support Band In $33.50-$34.00 - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Pfizer Inc. (NYSE:PFE) spent the last trading session almost flat as it ended the day with a minor loss of 0.55% but the next trading [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-testing-support-band-in-33-50-34-00-35402\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2015-04-30T12:26:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/Pfizer-Inc..jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"259\" \/>\n\t<meta property=\"og:image:height\" content=\"194\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Lisa Ray\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lisa Ray\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-testing-support-band-in-33-50-34-00-35402#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-testing-support-band-in-33-50-34-00-35402\"},\"author\":{\"name\":\"Lisa Ray\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/c58aa72f5e3994c817e3654937496b1c\"},\"headline\":\"Pfizer Inc. (NYSE:PFE) \u2013 Testing Support Band In $33.50-$34.00\",\"datePublished\":\"2015-04-30T12:26:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-testing-support-band-in-33-50-34-00-35402\"},\"wordCount\":301,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-testing-support-band-in-33-50-34-00-35402#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/Pfizer-Inc..jpg\",\"keywords\":[\"Astrazeneca Plc (ADR) (NYSE:AZN)\",\"GlaxoSmithKline plc (ADR) (NYSE:GSK)\",\"NYSE:AZN\",\"NYSE:GSK\",\"NYSE:PFE\",\"Pfizer Inc (NYSE:PFE)\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-testing-support-band-in-33-50-34-00-35402#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-testing-support-band-in-33-50-34-00-35402\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-testing-support-band-in-33-50-34-00-35402\",\"name\":\"Pfizer Inc. (NYSE:PFE) \u2013 Testing Support Band In $33.50-$34.00 - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-testing-support-band-in-33-50-34-00-35402#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-testing-support-band-in-33-50-34-00-35402#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/Pfizer-Inc..jpg\",\"datePublished\":\"2015-04-30T12:26:40+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-testing-support-band-in-33-50-34-00-35402#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-testing-support-band-in-33-50-34-00-35402\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-testing-support-band-in-33-50-34-00-35402#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/Pfizer-Inc..jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/Pfizer-Inc..jpg\",\"width\":259,\"height\":194},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-testing-support-band-in-33-50-34-00-35402#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pfizer Inc. (NYSE:PFE) \u2013 Testing Support Band In $33.50-$34.00\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/c58aa72f5e3994c817e3654937496b1c\",\"name\":\"Lisa Ray\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/2b2b9819092dcc9a125cbbf7b3645b09.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/2b2b9819092dcc9a125cbbf7b3645b09.png\",\"caption\":\"Lisa Ray\"},\"description\":\"Lisa has a Bachelor of Arts in journalism from Purdue University and 3 years of experience in the publishing field.\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/linsay-thomas\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pfizer Inc. (NYSE:PFE) \u2013 Testing Support Band In $33.50-$34.00 - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-testing-support-band-in-33-50-34-00-35402","og_locale":"en_US","og_type":"article","og_title":"Pfizer Inc. (NYSE:PFE) \u2013 Testing Support Band In $33.50-$34.00 - Wall Street PR","og_description":"Pfizer Inc. (NYSE:PFE) spent the last trading session almost flat as it ended the day with a minor loss of 0.55% but the next trading [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-testing-support-band-in-33-50-34-00-35402","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2015-04-30T12:26:40+00:00","og_image":[{"width":259,"height":194,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/Pfizer-Inc..jpg","type":"image\/jpeg"}],"author":"Lisa Ray","twitter_misc":{"Written by":"Lisa Ray","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-testing-support-band-in-33-50-34-00-35402#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-testing-support-band-in-33-50-34-00-35402"},"author":{"name":"Lisa Ray","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/c58aa72f5e3994c817e3654937496b1c"},"headline":"Pfizer Inc. (NYSE:PFE) \u2013 Testing Support Band In $33.50-$34.00","datePublished":"2015-04-30T12:26:40+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-testing-support-band-in-33-50-34-00-35402"},"wordCount":301,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-testing-support-band-in-33-50-34-00-35402#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/Pfizer-Inc..jpg","keywords":["Astrazeneca Plc (ADR) (NYSE:AZN)","GlaxoSmithKline plc (ADR) (NYSE:GSK)","NYSE:AZN","NYSE:GSK","NYSE:PFE","Pfizer Inc (NYSE:PFE)"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-testing-support-band-in-33-50-34-00-35402#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-testing-support-band-in-33-50-34-00-35402","url":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-testing-support-band-in-33-50-34-00-35402","name":"Pfizer Inc. (NYSE:PFE) \u2013 Testing Support Band In $33.50-$34.00 - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-testing-support-band-in-33-50-34-00-35402#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-testing-support-band-in-33-50-34-00-35402#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/Pfizer-Inc..jpg","datePublished":"2015-04-30T12:26:40+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-testing-support-band-in-33-50-34-00-35402#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-testing-support-band-in-33-50-34-00-35402"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-testing-support-band-in-33-50-34-00-35402#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/Pfizer-Inc..jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/Pfizer-Inc..jpg","width":259,"height":194},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-testing-support-band-in-33-50-34-00-35402#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Pfizer Inc. (NYSE:PFE) \u2013 Testing Support Band In $33.50-$34.00"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/c58aa72f5e3994c817e3654937496b1c","name":"Lisa Ray","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/2b2b9819092dcc9a125cbbf7b3645b09.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/2b2b9819092dcc9a125cbbf7b3645b09.png","caption":"Lisa Ray"},"description":"Lisa has a Bachelor of Arts in journalism from Purdue University and 3 years of experience in the publishing field.","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/linsay-thomas"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/35402","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=35402"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/35402\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/27742"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=35402"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=35402"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=35402"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=35402"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}